Eurofins Genomics LLC
Louisville, KY Part of Eurofins Genomics US Holdings, LLC
- UEI
- GE75H6G8HKM5
- CAGE
- 3YJT4
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
LR3FJAJU2J74
-
- D91NZL9CTNK3
-
-
Parent
LR3FJAJU2J74
- SAM.gov registration date
- Physical address
- 12621 Plantside Dr, Louisville, KY 40299, USA
- Website
- eurofinsgenomics.com
- Founded
- 1986
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $32,845 |
| FY2025 | $5,973 |
| FY2024 | $187,393 |
| FY2023 | $280,410 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Agriculture | $30,845 | |
| 2 | Department of Health and Human Services | $2,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| I D T | Coralville, IA | 325199 All Other Basic Organic Chemical Manufacturing |
| Illumina, Inc. | San Diego, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Seqwell Inc. | Beverly, MA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Cosmosid, Inc. | Rockville, MD | 541690 Other Scientific and Technical Consulting Services |
| Psomagen Inc. | Rockville, MD | 621511 Medical Laboratories |
About the company
Eurofins Genomics LLC, a for-profit manufacturer of genomic products and services headquartered in Louisville, Kentucky, operates exclusively as a prime contractor to federal research and public-health agencies, competing full-and-open with no set-aside designations across its 145 awards. The vendor is a subsidiary of Eurofins Genomics US Holdings, LLC, a foreign-owned parent entity; a named subsidiary, Mwg-Biotech, Inc., operates under the Eurofins umbrella.
Eurofins delivers custom oligonucleotide synthesis, DNA sequencing (including Sanger, Next-Generation, and Nanopore platforms), plasmid sequencing, and genomic analysis services to support biomedical research, infectious-disease surveillance, and pandemic-preparedness programs. Representative work includes a $24.1 million definitive contract from the Office of the Assistant Secretary for Preparedness and Response for COVID-19 supply-chain industrial-base expansion and medical-equipment sourcing (transitioned from a prior Air Force award), a $63,450 firm-fixed-price contract from USDA APHIS for high-volume DNA sequencing supporting the National Wildlife Research Center's Chronic Wasting Disease research with 99% accuracy and overnight-delivery performance requirements, and a $10 million single-award BPA from the National Institute of Neurological Disorders and Stroke covering custom oligonucleotides and sequencing services with an ultimate completion date of March 31, 2026.
Customer concentration centers on HHS research and public-health agencies. The Department of Health and Human Services dominates both award count and potential value: the National Institute of Allergy and Infectious Diseases leads by count with 11 awards worth $49 thousand combined potential value, while the NIH Office of Logistics and Acquisition Operations anchors the value ranking with 3 awards totaling $10 million combined potential value, driven by the NINDS $10 million BPA. The Department of the Navy Bureau of Medicine and Surgery rounds out the top tier with 10 awards worth $417 thousand combined potential value. The top five customer organizations account for 31% of awards across 28 distinct federal agencies. Eurofins places task orders under three primary BPAs: HHSN263200500062535B (10 task orders, $42 thousand combined potential value), HHSN263201500064B (8 task orders, $25 thousand combined potential value), and 75N98024A00124 (4 task orders, $35 thousand combined potential value).
Award activity has modulated with a trend toward larger single contracts: two awards in 2021 and 2022, four in 2023, seven in 2024, and three in 2026. Only one award faces recompete inside the next twenty-four months. NAICS concentration splits across In-Vitro Diagnostic Substance Manufacturing (32 awards), Research and Development in Biotechnology (26 awards), and All Other Miscellaneous Manufacturing (17 awards); PSC concentration clusters in Laboratory Equipment and Supplies (52 awards) and Drugs and Biologicals (24 awards). Combined potential value across all 145 awards is $42.2 million, with $32.3 million obligated (77% drawdown).
Quick answers
Is Eurofins Genomics LLC registered in SAM.gov?
Yes. Eurofins Genomics LLC's SAM.gov registration is active through April 21, 2027.
How much has Eurofins Genomics LLC received in federal contracts?
Federal contracts obligated $5,973 to Eurofins Genomics LLC in fiscal year 2025 and $506,622 in fiscal years 2023 through 2027.
What is Eurofins Genomics LLC's most recent federal award?
Eurofins Genomics LLC's most recent federal contract award is The national wildlife research center's CWD project collects samples and conducts DNA extraction at the nwrc… (12639526C0058), from Marketing and Regulatory Programs Business Services (APHIS), on September 29, 2026.
On GovTribe
See Eurofins Genomics LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors